Callan Family Office’s CVS Health CVS Stock Holding History

Callan Family Office’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.9M	Buy	165,103 +9,799	+6%	+$755K	0.27%	73
2025 Q4	$12.3M	Buy	155,304 +19,988	+15%	+$1.58M	0.26%	71
2025 Q3	$10.2M	Buy	135,316 +14,208	+12%	+$974K	0.33%	60
2025 Q2	$8.35M	Buy	121,108 +89,053	+278%	+$5.84M	0.26%	77
2025 Q1	$2.17M	Buy	32,055 +11,890	+59%	+$712K	0.16%	121
2024 Q4	$905K	Buy	+20,165	New	+$1.13M	0.06%	269
2024 Q2	–	Sell	-3,164	Closed	-$252K	–	154
2024 Q1	$252K	Buy	3,164 +415	+15%	+$31.7K	0.06%	84
2023 Q4	$217K	Buy	+2,749	New	+$196K	0.05%	95
2023 Q2	–	Sell	-12,871	Closed	-$956K	–	124
2023 Q1	$956K	Buy	12,871 +10,701	+493%	+$897K	0.23%	63
2022 Q4	$202K	Buy	+2,170	New	+$209K	0.07%	101

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Callan Family Office's CVS Position: Q1 2026 in Review

Callan Family Office increased its CVS Health (CVS) stake by 6.3% in Q1 2026, buying an estimated $755K and bringing the position to 165,103 shares worth $11.9M. The position accounts for 0.27% of the portfolio, ranked #73.

Callan Family Office first reported a position in CVS in Q4 2022 and has held it in 10 quarters since. The position peaked at $12.3M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Callan Family Office held 165,103 shares of CVS Health worth $11.9M as of Q1 2026.
Callan Family Office bought 9,799 CVS Health shares in Q1 2026, an estimated $755K.
CVS Health made up 0.27% of Callan Family Office's portfolio in Q1 2026, its #73 holding.
Callan Family Office first reported a position in CVS Health in Q4 2022 and has held it in 10 quarters since.
Callan Family Office's CVS Health position peaked at $12.3M in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.